RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021
October 27 2021 - 3:05PM
RxSight, Inc., an ophthalmic medical device company, today
announced that it will report financial results for the third
quarter of 2021 after the market close on Wednesday, November 10,
2021. The company’s management will discuss the results during a
conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m.
Eastern Time.
Investors interested in listening to the conference
call may do so by accessing a live and archived webcast of the
event at www.rxsight.com, on the Investors page in the News and
Events section. The call will also be available by dialing
844-602-7038 (U.S.) or 916-637-9714 (International) five to ten
minutes prior to the start time, using conference ID: 1239025.
About RxSight, Inc.RxSight, Inc.
is a commercial-stage medical technology company dedicated to
improving the vision of patients following cataract surgery. The
RxSight Light Adjustable Lens system, comprised of the RxSight
Light Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD™)
and accessories, is the first and only commercially available
intraocular lens (IOL) technology that enables doctors to customize
and optimize visual acuity for patients after cataract surgery. The
LAL now features ActivShield™ technology, a revolutionary UV
protection layer built into the lens. Additional information about
RxSight® can be found at www.rxsight.com.
Investor Relations Contact:Philip
Taylor Gilmartin Group415.937.5406IR@rxsight.com
Company contact:Roy FreemanSr.
Director, Marketingrfreeman@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jun 2024 to Jul 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2023 to Jul 2024